Cited by

• High seroprevalence of Rift Valley FEVER AND EVIDENCE FOR ENDEMIC circulation in Mbeya region, Tanzania, in a cross-sectional study.

  Heinrich N, Saathoff E, Weller N, Clowes P, Kroidl I, Ntinginya E, Machibya H, Maboko L, Löscher T, Dobler G, Hoelscher M. Heinrich N, et al. PLoS Negl Trop Dis. 2012;6(3):e1557. doi: 10.1371/journal.pntd.0001557. Epub 2012 Mar 27. PLoS Negl Trop Dis. 2012. PMID: 22479657 Free PMC article.
• Experimental transmission of West Nile Virus and Rift Valley Fever Virus by Culex pipiens from Lebanon.

  Zakhia R, Mousson L, Vazeille M, Haddad N, Failloux AB. Zakhia R, et al. PLoS Negl Trop Dis. 2018 Jan 11;12(1):e0005983. doi: 10.1371/journal.pntd.0005983. eCollection 2018 Jan. PLoS Negl Trop Dis. 2018. PMID: 29324834 Free PMC article.
• Biologically Informed Individual-Based Network Model for Rift Valley Fever in the US and Evaluation of Mitigation Strategies.

  Scoglio CM, Bosca C, Riad MH, Sahneh FD, Britch SC, Cohnstaedt LW, Linthicum KJ. Scoglio CM, et al. PLoS One. 2016 Sep 23;11(9):e0162759. doi: 10.1371/journal.pone.0162759. eCollection 2016. PLoS One. 2016. PMID: 27662585 Free PMC article.
• Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.

  Ikegami T, Balogh A, Nishiyama S, Lokugamage N, Saito TB, Morrill JC, Shivanna V, Indran SV, Zhang L, Smith JK, Perez D, Juelich TL, Morozov I, Wilson WC, Freiberg AN, Richt JA. Ikegami T, et al. PLoS One. 2017 Dec 21;12(12):e0189250. doi: 10.1371/journal.pone.0189250. eCollection 2017. PLoS One. 2017. PMID: 29267298 Free PMC article.
• Comparative thermo-stability of two Rift Valley fever virus vaccine candidate CL13T with a recombinant arMP-12ΔNSm21/384.

  Daouam S, Boumart Z, Elarkam A, Hamdi J, Tadlaoui KO, Ennaji MM, Harraka M. Daouam S, et al. Bioinformation. 2020 Jul 31;16(7):547-554. doi: 10.6026/97320630016547. eCollection 2020. Bioinformation. 2020. PMID: 32994680 Free PMC article.